Scandinavian Multicenter Acute Subdural Hematoma (SMASH) Study: Study Protocol for a Multinational Population-Based Consecutive Cohort.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 04 03 2018
accepted: 04 04 2018
pubmed: 16 5 2018
medline: 2 1 2020
entrez: 16 5 2018
Statut: ppublish

Résumé

Traumatic acute subdural hematomas (ASDHs) are associated with high rate of morbidity and mortality, especially in elderly individuals. However, recent reports indicate that the morbidity and mortality rates might have improved. To evaluate postoperative (30-d) mortality in younger vs elderly (≥70 yr) patients with ASDH. Comparing younger and elderly patients, the secondary objectives are morbidity patterns of care and 6 mo outcome according to Glasgow outcome scale (GOS). Finally, in patients with traumatic ASDH, we aim to provide prognostic variables. This is a large-scale population-based Scandinavian study including all neurosurgical departments in Denmark and Sweden. All adult (≥18 yr) patients surgically treated between 2010 and 2014 for a traumatic ASDH in Denmark and Sweden will be included. Identification at clinicaltrials.gov is NCT03284190. We expect to provide data on potential differences between younger vs elderly patients in terms of mortality and morbidity. We hypothesize that elderly patients selected for surgery have a similar pattern of care as compared with younger patients. We will provide functional outcome in terms of GOS at 6 mo in younger vs elderly patients undergoing ASDH evacuation. Finally, clinical useful prognostic factors for favorable (GOS 4-5) vs unfavorable (GOS 1-3) will be identified. An improved understanding of the clinical outcome, treatment and resource allocation, clinical course, and the prognostic factors of traumatic ASDH will allow neurosurgeons to make better treatment decisions.

Sections du résumé

BACKGROUND
Traumatic acute subdural hematomas (ASDHs) are associated with high rate of morbidity and mortality, especially in elderly individuals. However, recent reports indicate that the morbidity and mortality rates might have improved.
OBJECTIVE
To evaluate postoperative (30-d) mortality in younger vs elderly (≥70 yr) patients with ASDH. Comparing younger and elderly patients, the secondary objectives are morbidity patterns of care and 6 mo outcome according to Glasgow outcome scale (GOS). Finally, in patients with traumatic ASDH, we aim to provide prognostic variables.
METHODS
This is a large-scale population-based Scandinavian study including all neurosurgical departments in Denmark and Sweden. All adult (≥18 yr) patients surgically treated between 2010 and 2014 for a traumatic ASDH in Denmark and Sweden will be included. Identification at clinicaltrials.gov is NCT03284190.
EXPECTED OUTCOMES
We expect to provide data on potential differences between younger vs elderly patients in terms of mortality and morbidity. We hypothesize that elderly patients selected for surgery have a similar pattern of care as compared with younger patients. We will provide functional outcome in terms of GOS at 6 mo in younger vs elderly patients undergoing ASDH evacuation. Finally, clinical useful prognostic factors for favorable (GOS 4-5) vs unfavorable (GOS 1-3) will be identified.
DISCUSSION
An improved understanding of the clinical outcome, treatment and resource allocation, clinical course, and the prognostic factors of traumatic ASDH will allow neurosurgeons to make better treatment decisions.

Identifiants

pubmed: 29762769
pii: 4995605
doi: 10.1093/neuros/nyy173
doi:

Banques de données

ClinicalTrials.gov
['NCT03284190']

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

799-803

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2018 by the Congress of Neurological Surgeons.

Auteurs

Jiri Bartek (J)

Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Denmark.
Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.

Christian Laugesen (C)

Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Denmark.

Sadia Mirza (S)

Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.

Axel Forsse (A)

Department of Neurosurgery, Odense University Hospital, Odense, Denmark.

Michael Anders Petersen (MA)

Department of Neurosurgery, Odense University Hospital, Odense, Denmark.

Alba Corell (A)

Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Philip Wilhelm Dyhrfort (PW)

Department of Neurosurgery, Uppsala University Hospital, Uppsala Sweden.

Henrietta Nittby Redebrandt (HN)

Department of Neurosurgery, Lund University Hospital, Lund, Sweden.

Linus Reen (L)

Department of Neurosurgery, Lund University Hospital, Lund, Sweden.

Shaian Zolfaghari (S)

Department of Neurosurgery, Lund University Hospital, Lund, Sweden.

Lovisa Tobieson (L)

Department of Neurosurgery, Linköping University Hospital, Linköping, Sweden.

Björn Carlsvärd (B)

Department of Neurosurgery, Linköping University Hospital, Linköping, Sweden.

Bo Bergholt (B)

Department of Neurosurgery, Århus University Hospital, Århus, Denmark.

Asma Bashir (A)

Department of Neurosurgery, Århus University Hospital, Århus, Denmark.

Preben Soerensen (P)

Department of Neurosurgery, Ålborg University Hospital, Ålborg, Denmark.

Arzu Bilgin (A)

Department of Neurosurgery, Ålborg University Hospital, Ålborg, Denmark.

Conny Johansson (C)

Department of Neurosurgery, Umeå University Hospital, Umeå, Sweden.

Peter Lindvall (P)

Department of Neurosurgery, Umeå University Hospital, Umeå, Sweden.

Petter Förander (P)

Department of Neurosurgery, Uppsala University Hospital, Uppsala Sweden.

Bo-Michael Bellander (BM)

Department of Neurosurgery, Karolinska University Hospital, Stockholm, Sweden.

Jacob B Springborg (JB)

Department of Neurosurgery, Copenhagen University Hospital Rigshospitalet, Denmark.

Asgeir S Jakola (AS)

Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Institute of Neuroscience and Physiology, Sahlgrenska Academy, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH